BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21923187)

  • 1. A new phenylalanine derivative acts as an antagonist at the AMPA receptor GluA2 and introduces partial domain closure: synthesis, resolution, pharmacology, and crystal structure.
    Szymańska E; Frydenvang K; Contreras-Sanz A; Pickering DS; Frola E; Serafimoska Z; Nielsen B; Kastrup JS; Johansen TN
    J Med Chem; 2011 Oct; 54(20):7289-98. PubMed ID: 21923187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization and binding modes of novel racemic and optically active phenylalanine-based antagonists of AMPA receptors.
    Szymańska E; Nielsen B; Johansen TN; Cuñado Moral AM; Pickering DS; Szczepańska K; Mickowska A; Kieć-Kononowicz K
    Eur J Med Chem; 2017 Sep; 138():874-883. PubMed ID: 28738307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and pharmacological characterization of phenylalanine-based AMPA receptor antagonists at kainate receptors.
    Venskutonytė R; Frydenvang K; Valadés EA; Szymańska E; Johansen TN; Kastrup JS; Pickering DS
    ChemMedChem; 2012 Oct; 7(10):1793-8. PubMed ID: 22407805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heteroaryl analogues of AMPA. 2. Synthesis, absolute stereochemistry, photochemistry, and structure-activity relationships.
    Falch E; Brehm L; Mikkelsen I; Johansen TN; Skjaerbaek N; Nielsen B; Stensbøl TB; Ebert B; Krogsgaard-Larsen P
    J Med Chem; 1998 Jul; 41(14):2513-23. PubMed ID: 9651156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyr702 is an important determinant of agonist binding and domain closure of the ligand-binding core of GluR2.
    Frandsen A; Pickering DS; Vestergaard B; Kasper C; Nielsen BB; Greenwood JR; Campiani G; Fattorusso C; Gajhede M; Schousboe A; Kastrup JS
    Mol Pharmacol; 2005 Mar; 67(3):703-13. PubMed ID: 15591246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tweaking Subtype Selectivity and Agonist Efficacy at (S)-2-Amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)propionic acid (AMPA) Receptors in a Small Series of BnTetAMPA Analogues.
    Wang SY; Larsen Y; Navarrete CV; Jensen AA; Nielsen B; Al-Musaed A; Frydenvang K; Kastrup JS; Pickering DS; Clausen RP
    J Med Chem; 2016 Mar; 59(5):2244-54. PubMed ID: 26862980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMPA receptor agonists: resolution, configurational assignment, and pharmacology of (+)-(S)- and (-)-(R)-2-amino-3-[3-hydroxy-5-(2-pyridyl)-isoxazol-4-yl]-propionic acid (2-Py-AMPA).
    Johansen TN; Ebert B; Falch E; Krogsgaard-Larsen P
    Chirality; 1997; 9(3):274-80. PubMed ID: 9176992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tetrazolyl-substituted subtype-selective AMPA receptor agonist.
    Vogensen SB; Frydenvang K; Greenwood JR; Postorino G; Nielsen B; Pickering DS; Ebert B; Bølcho U; Egebjerg J; Gajhede M; Kastrup JS; Johansen TN; Clausen RP; Krogsgaard-Larsen P
    J Med Chem; 2007 May; 50(10):2408-14. PubMed ID: 17455929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (S)-2-Amino-3-(3-hydroxy-7,8-dihydro-6H-cyclohepta[d]isoxazol-4-yl)propionic acid, a potent and selective agonist at the GluR5 subtype of ionotropic glutamate receptors. Synthesis, modeling, and molecular pharmacology.
    Brehm L; Greenwood JR; Hansen KB; Nielsen B; Egebjerg J; Stensbøl TB; Bräuner-Osborne H; Sløk FA; Kronborg TT; Krogsgaard-Larsen P
    J Med Chem; 2003 Apr; 46(8):1350-8. PubMed ID: 12672235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, theoretical and structural analyses, and enantiopharmacology of 3-carboxy homologs of AMPA.
    Brehm L; Greenwood JR; Sløk FA; Holm MM; Nielsen B; Geneser U; Stensbøl TB; Bräuner-Osborne H; Begtrup M; Egebjerg J; Krogsgaard-Larsen P
    Chirality; 2004 Aug; 16(7):452-66. PubMed ID: 15236343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-hydroxypyridazine 1-oxides as carboxylate bioisosteres: a new series of subtype-selective AMPA receptor agonists.
    Greenwood JR; Mewett KN; Allan RD; Martín BO; Pickering DS
    Neuropharmacology; 2006 Jul; 51(1):52-9. PubMed ID: 16631211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-Substituted phenylalanines as selective AMPA- and kainate receptor ligands.
    Szymańska E; Pickering DS; Nielsen B; Johansen TN
    Bioorg Med Chem; 2009 Sep; 17(17):6390-401. PubMed ID: 19656686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on Aryl-Substituted Phenylalanines: Synthesis, Activity, and Different Binding Modes at AMPA Receptors.
    Szymanska E; Frydenvang K; Pickering DS; Krintel C; Nielsen B; Kooshki A; Zachariassen LG; Olsen L; Kastrup JS; Johansen TN
    J Med Chem; 2016 Jan; 59(1):448-61. PubMed ID: 26653877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and pharmacology of a highly subtype-selective GluR1/2 agonist, (RS)-2-amino-3-(4-chloro-3-hydroxy-5-isoxazolyl)propionic acid (Cl-HIBO).
    Bjerrum EJ; Kristensen AS; Pickering DS; Greenwood JR; Nielsen B; Liljefors T; Schousboe A; Bräuner-Osborne H; Madsen U
    J Med Chem; 2003 May; 46(11):2246-9. PubMed ID: 12747796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aryl- and heteroaryl-substituted phenylalanines as AMPA receptor ligands.
    Szymańska E; Chałupnik P; Johansen TN; Nielsen B; Cuñado Moral AM; Pickering DS; Więckowska A; Kieć-Kononowicz K
    Chem Biol Drug Des; 2017 Dec; 90(6):1271-1281. PubMed ID: 28636281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 8-(1H-imidazol-1-yl)-7-nitro-4(5H)-imidazo[1,2-alpha]quinoxalinone and related compounds: synthesis and structure-activity relationships for the AMPA-type non-NMDA receptor.
    Ohmori J; Shimizu-Sasamata M; Okada M; Sakamoto S
    J Med Chem; 1997 Jun; 40(13):2053-63. PubMed ID: 9207947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-hydroxy-1,2,5-oxadiazol-3-yl moiety as bioisoster of the carboxy function. Synthesis, ionization constants, and molecular pharmacological characterization at ionotropic glutamate receptors of compounds related to glutamate and its homologues.
    Lolli ML; Giordano C; Pickering DS; Rolando B; Hansen KB; Foti A; Contreras-Sanz A; Amir A; Fruttero R; Gasco A; Nielsen B; Johansen TN
    J Med Chem; 2010 May; 53(10):4110-8. PubMed ID: 20408529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereostructure-activity studies on agonists at the AMPA and kainate subtypes of ionotropic glutamate receptors.
    Johansen TN; Greenwood JR; Frydenvang K; Madsen U; Krogsgaard-Larsen P
    Chirality; 2003 Feb; 15(2):167-79. PubMed ID: 12520509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for AMPA receptor activation and ligand selectivity: crystal structures of five agonist complexes with the GluR2 ligand-binding core.
    Hogner A; Kastrup JS; Jin R; Liljefors T; Mayer ML; Egebjerg J; Larsen IK; Gouaux E
    J Mol Biol; 2002 Sep; 322(1):93-109. PubMed ID: 12215417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of Tet-AMPA [tetrazolyl-2-amino-3-(3-hydroxy-5-methyl- 4-isoxazolyl)propionic acid] analogues at ionotropic glutamate receptors GluR1-GluR4. The molecular basis for the functional selectivity profile of 2-Bn-Tet-AMPA.
    Jensen AA; Christesen T; Bølcho U; Greenwood JR; Postorino G; Vogensen SB; Johansen TN; Egebjerg J; Bräuner-Osborne H; Clausen RP
    J Med Chem; 2007 Aug; 50(17):4177-85. PubMed ID: 17672447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.